Rhamnazin attenuates Amyloid β-Peptide (1–42) induced spatial memory impairments by modulation of BDNF-ERK signaling pathway
Sajjad Jabbari, Zainul Amiruddin Zakaria, Irwin Rose Alencar de Menezes, Saeed Mohammadi · 2026
Read Rhamnazin attenuates Amyloid β-Peptide (1–42) induced spatial memory impairments by modulation of BDNF-ERK signaling pathway by Sajjad Jabbari, Zainul Amiruddin Zakaria, Irwin Rose Alencar de Menezes, Saeed Mohammadi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13181119.txt.
Description
Sajjad Jabbari and co-authors report a rat study from 2026 on rhamnazin, a natural plant compound, and memory loss linked to Alzheimer disease. Rats were given amyloid beta peptide in the brain, which harmed their working memory and their sense of place. The team then tested whether daily doses of rhamnazin could protect the brain.
Rats that got rhamnazin for five days in a row did better on memory tests, and the gain grew with the dose. A single dose did not help. The treated rats also showed higher levels of BDNF and active ERK in the hippocampus, two signals tied to learning. The work hints at a drug lead, though tests in people are still far off.
Catalog record
| CREATOR | Sajjad Jabbari, Zainul Amiruddin Zakaria, Irwin Rose Alencar de Menezes, Saeed Mohammadi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |